Our involvement in research and Dr. Sloan’s involvement with the pharmaceutical industry allow us and you to participate in clinical trials that may offer you new treatments before they are widely available. Clinical trials provide important information that is essential to develop better treatments for diseases. Participating in a clinical trial is a personal decision, and it is important to talk to your physician and family members about it. Participants in clinical trials receive exceptional care and study medications throughout the study at no cost. To learn more about participating in a clinical trial, check the website of the National Institutes of Health.

Take a look at our ongoing clinical trials and check if you, a member of your family, or a friend would meet the inclusion criteria:

Cardiovascular Diseases

SURMOUNT Clinical Trial – Tirzepatide

Eligible participants must meet the following criteria:

- Be at least 40 years of age

- Have a BMI of 27.0 kg/m2 or higher

- Have either established cardiovascular disease or cardiovascular risk factors

- NOT have type 1 or type 2 diabetes

ZEUS Clinical Trial – Ziltivekimab (anti-inflammatory monoclonal antibody)

Eligible participants must meet the following criteria:

- Have Renal impairment – eGFR between ≥15 and <60 mL/Min/1.73m²

- Have evidence of ASCVD (Coronary Heart Disease, Cerebrovascular Disease, Symptomatic PAD)

CATALYST Clinical Trial – Korlym (Study of Hypercortisolism in Patients with Difficult to Control Type 2 Diabetes Despite Receiving Standard-of-Care Therapies: Prevalence and Treatment with Korlym)

Eligible participants must meet the following criteria:

- age 18 to 80 years old with difficult to control Type 2 Diabetes (HbA1c >= 7.5% and <= 11.5%, AND

- taking 3 or more anti-hyperglycemic drugs, OR

- taking insulin and other anti-hyperglycemic drugs, OR

- taking 2 or more anti-hyperglycemic drugs and presence of microvascular complications and/or concomitant hypertension requiring 2 or more anti-hypertension medications